Literature DB >> 28165741

Structural Analysis of Chemokine Receptor-Ligand Interactions.

Marta Arimont1, Shan-Liang Sun1, Rob Leurs1, Martine Smit1, Iwan J P de Esch1, Chris de Graaf1.   

Abstract

This review focuses on the construction and application of structural chemokine receptor models for the elucidation of molecular determinants of chemokine receptor modulation and the structure-based discovery and design of chemokine receptor ligands. A comparative analysis of ligand binding pockets in chemokine receptors is presented, including a detailed description of the CXCR4, CCR2, CCR5, CCR9, and US28 X-ray structures, and their implication for modeling molecular interactions of chemokine receptors with small-molecule ligands, peptide ligands, and large antibodies and chemokines. These studies demonstrate how the integration of new structural information on chemokine receptors with extensive structure-activity relationship and site-directed mutagenesis data facilitates the prediction of the structure of chemokine receptor-ligand complexes that have not been crystallized. Finally, a review of structure-based ligand discovery and design studies based on chemokine receptor crystal structures and homology models illustrates the possibilities and challenges to find novel ligands for chemokine receptors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28165741      PMCID: PMC5483895          DOI: 10.1021/acs.jmedchem.6b01309

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  245 in total

1.  Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

Authors:  Michael M Mysinger; Dahlia R Weiss; Joshua J Ziarek; Stéphanie Gravel; Allison K Doak; Joel Karpiak; Nikolaus Heveker; Brian K Shoichet; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  Global mapping of pharmacological space.

Authors:  Gaia V Paolini; Richard H B Shapland; Willem P van Hoorn; Jonathan S Mason; Andrew L Hopkins
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

3.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

4.  Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.

Authors:  L O Gerlach; R T Skerlj; G J Bridger; T W Schwartz
Journal:  J Biol Chem       Date:  2001-01-11       Impact factor: 5.157

5.  1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity.

Authors:  J J Hale; R J Budhu; E B Holson; P E Finke; B Oates; S G Mills; M MacCoss; S L Gould; J A DeMartino; M S Springer; S Siciliano; L Malkowitz; W A Schleif; D Hazuda; M Miller; J Kessler; R Danzeisen; K Holmes; J Lineberger; A Carella; G Carver; E Emini
Journal:  Bioorg Med Chem Lett       Date:  2001-10-22       Impact factor: 2.823

6.  Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor.

Authors:  Paola Casarosa; Wiro M Menge; Rosalba Minisini; Claas Otto; Jane van Heteren; Aldo Jongejan; Henk Timmerman; Barbara Moepps; Frank Kirchhoff; Thomas Mertens; Martine J Smit; Rob Leurs
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

7.  CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.

Authors:  Shou-Fu Lu; Binglong Chen; Dave Davey; Laura Dunning; Stefan Jaroch; Karen May; James Onuffer; Gary Phillips; Babu Subramanyam; Jih-Lie Tseng; Robert G Wei; Ming Wei; Bin Ye
Journal:  Bioorg Med Chem Lett       Date:  2007-01-25       Impact factor: 2.823

8.  Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.

Authors:  Melanie P Wescott; Irina Kufareva; Cheryl Paes; Jason R Goodman; Yana Thaker; Bridget A Puffer; Eli Berdougo; Joseph B Rucker; Tracy M Handel; Benjamin J Doranz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-19       Impact factor: 11.205

9.  Antagonism of human CC-chemokine receptor 4 can be achieved through three distinct binding sites on the receptor.

Authors:  Robert J Slack; Linda J Russell; Nick P Barton; Cathryn Weston; Giovanna Nalesso; Sally-Anne Thompson; Morven Allen; Yu Hua Chen; Ashley Barnes; Simon T Hodgson; David A Hall
Journal:  Pharmacol Res Perspect       Date:  2013-12-30

10.  Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.

Authors:  Juan Xu; Xiyun Deng; Min Tang; Lili Li; Lanbo Xiao; Lifang Yang; Juanfang Zhong; Ann M Bode; Zigang Dong; Yongguang Tao; Ya Cao
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  26 in total

1.  In Vitro Assay to Study Tumor-macrophage Interaction.

Authors:  Zhenyi An; William A Weiss
Journal:  J Vis Exp       Date:  2019-08-01       Impact factor: 1.355

2.  Comparative modeling and docking of chemokine-receptor interactions with Rosetta.

Authors:  Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman
Journal:  Biochem Biophys Res Commun       Date:  2020-01-07       Impact factor: 3.575

3.  Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Authors:  Jamie C Fox; Monica A Thomas; Acacia F Dishman; Olav Larsen; Takashi Nakayama; Osamu Yoshie; Mette Marie Rosenkilde; Brian F Volkman
Journal:  Sci Signal       Date:  2019-09-03       Impact factor: 8.192

Review 4.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

Review 5.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

6.  Modeling the complete chemokine-receptor interaction.

Authors:  Michael J Wedemeyer; Benjamin K Mueller; Brian J Bender; Jens Meiler; Brian F Volkman
Journal:  Methods Cell Biol       Date:  2018-11-01       Impact factor: 1.441

7.  Molecular insights into mechanisms of GPCR hijacking by Staphylococcus aureus.

Authors:  Claire M Grison; Paul Lambey; Sylvain Jeannot; Elise Del Nero; Simon Fontanel; Fanny Peysson; Joyce Heuninck; Rémy Sounier; Thierry Durroux; Cédric Leyrat; Sébastien Granier; Cherine Bechara
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

8.  Engineering Salt Bridge Networks between Transmembrane Helices Confers Thermostability in G-Protein-Coupled Receptors.

Authors:  Soumadwip Ghosh; Tobias Bierig; Sangbae Lee; Suvamay Jana; Adelheid Löhle; Gisela Schnapp; Christofer S Tautermann; Nagarajan Vaidehi
Journal:  J Chem Theory Comput       Date:  2018-11-06       Impact factor: 6.006

Review 9.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

10.  Discovery of Novel CCR5 Ligands as Anticolorectal Cancer Agents by Sequential Virtual Screening.

Authors:  Mariam A El-Zohairy; Darius P Zlotos; Martin R Berger; Hassan H Adwan; Yasmine M Mandour
Journal:  ACS Omega       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.